2022 Annual Meeting | S33 - Cerebrovascular Disease: Basic Sciences and Cohort Studies

Date Wednesday 04/06/22

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Ajay M. Tunguturi, MD, Adam De Havenon, MD, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

CME Available 2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:30 PM PDT	Speaker	Walk-in Slides Erin Jackson
03:30 PM - 03:42 PM PDT	Abstract	001 - Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood-Brain Barrier after Stroke Amjad Shehadah, MD
03:42 PM - 03:54 PM PDT	Abstract	002 - Role of ACE Polymorphism in Acute Ischemic Stroke Alvee Saluja, DM
03:54 PM - 04:06 PM PDT	Abstract	003 - Skin Capillary Amylin Deposition Resembles Brain Amylin Vasculopathy Saurav Das, MD
04:06 PM - 04:18 PM PDT	Abstract	004 - Correlation between Optical Coherence Tomography Angiography ( OCT- A) changes at 3 to 6 weeks and functional outcome ( modified Rankin Scale – mRS) at 3 months of onset of acute ischemic stroke due to Extracranial Internal Carotid Artery Atherosclerotic Disease (ECAD) Biswamohan Mishra
04:18 PM - 04:30 PM PDT	Abstract	005 - Association of Plasma NfL Levels with Risk of Cardiovascular Disease in the Framingham Heart Study Hugo Javier Aparicio, MD, MPH
04:30 PM - 04:42 PM PDT	Abstract	006 - Sirtuin 1 Mediated Modulation of Inflammasome Signaling Confers Neuroprotection in Rodent Model of Ischemic Stroke Following Endovascular Mesenchymal Stem Cell Therapy Deepaneeta Sarmah, M Pharm
04:42 PM - 04:54 PM PDT	Abstract	007 - Correlation Between Serum Low Density Lipoprotein (ldl) Levels And Hemorrhagic Stroke Severity: A Retrospective Review From Siren (preliminary findings) Oladotun V. Olalusi, MBBS
04:54 PM - 05:06 PM PDT	Abstract	008 - Vascular Territories In Spinal Cord Strokes: Topographic Analysis In 61 Cases David Acero-Garces, MD
05:06 PM - 05:18 PM PDT	Abstract	009 - Temporal Evaluation of MicroRNA Expression profile in Acute Anterior Circulation Large Vessel Occlusion Stroke Shraddha Mainali, MD
05:18 PM - 05:30 PM PDT	Abstract	010 - Genetic Analyses Support a Causal Role of Lung Cancer in Ischemic Stroke Kevin N. Vanent

Faculty Disclosures
David Acero-Garces, MD	Dr. Acero-Garces has nothing to disclose.
Magdy H. Selim, MD, PhD	Dr. Selim has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. The institution of Dr. Selim has received research support from NIH/NINDS. Dr. Selim has received publishing royalties from a publication relating to health care.
	No disclosure on file
Audrey Leasure	Ms. Leasure has nothing to disclose.
Pallab Bhattacharya, PhD	Dr. Bhattacharya has nothing to disclose.
Vasileios-Arsenios Lioutas, MD	Dr. Lioutas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Qmetis. Dr. Lioutas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mindray. The institution of Dr. Lioutas has received research support from NIH. The institution of Dr. Lioutas has received research support from Alzheimer's Association.
Antra Chaudhary, MS (Pharm)	Ms. CHAUDHARY has nothing to disclose.
Dibya Himali	No disclosure on file
Cyprien Rivier, MD	Dr. Rivier has nothing to disclose.
Susana Dominguez Penuela, MD	Dr. Dominguez Penuela has nothing to disclose.
Jayandra Himali	Jayandra Himali has nothing to disclose.
Ankit Goyal	No disclosure on file
Eng Lo, MD	Eng Lo, MD has nothing to disclose.
Achal K. Srivastava, MD, FAAN	Dr. Srivastava has nothing to disclose.
Venugopalan Y. Vishnu, MD	The institution of Dr. Vishnu has received research support from Department of Health Research.
Claudia L. Satizabal, PhD	The institution of Dr. Satizabal has received research support from NIH and TARCC.
Dileep R. Yavagal, MD, FAAN	Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Padma V. Hadakasira, MD	Dr. Hadakasira has nothing to disclose.
Akintomiwa Makanjuola, MBBS	Dr. Makanjuola has nothing to disclose.
Shraddha Mainali, MD	Dr. Mainali has received personal compensation for serving as an employee of Virginia commonwealth University.
Alvee Saluja, DM	Dr. Saluja has nothing to disclose.
Jose R. Romero, MD	The institution of Dr. Romero has received research support from NIH/NIA.
Julian Acosta, MD	Dr. Acosta has nothing to disclose.
Adam De Havenon, MD, FAAN	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Kevin N. Vanent	Mr. Vanent has nothing to disclose.
Ajay Garg	Ajay Garg has nothing to disclose.
Biswamohan Mishra	Mr. Mishra has nothing to disclose.
Daniel Woo, MD, FAAN	The institution of Dr. Woo has received research support from NIH.
Rohit Bhatia, MD, MBBS, DM	Dr. Bhatia has nothing to disclose.
Deepaneeta Sarmah, M Pharm	Miss Sarmah has nothing to disclose.
Marc Fisher, MD, FAAN	Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SimcereUSA. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SimcereUSA. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNo. Dr. Fisher has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Victor M. Torres-Lopez, MA	Mr. Torres-Lopez has nothing to disclose.
Alexa Beiser	Alexa Beiser has nothing to disclose.
Michael Levitt	No disclosure on file
Mayowa Owolabi, MD, FAAN	Dr. Owolabi has nothing to disclose.
Guido J. Falcone, MD	The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Donna M. Wilcock, PhD	Dr. Wilcock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AC Immune. Dr. Wilcock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. Dr. Wilcock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AvroBio. Dr. Wilcock has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroscience.
Sudha Seshadri, MD, FAAN	Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Gregory A. Jicha, MD, PhD	Dr. Jicha has nothing to disclose.
Rufus O. Akinyemi, MD	Dr. Akinyemi has nothing to disclose.
Oladotun V. Olalusi, MBBS	Dr. Olalusi has nothing to disclose.
Amjad Shehadah, MD	Dr. Shehadah has nothing to disclose.
Shubham Misra, PhD	Dr. Misra has nothing to disclose.
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Natalia Szejko, MD, PhD	Dr. Szejko has nothing to disclose.
Erin Jackson	Ms. Jackson has received personal compensation for serving as an employee of the American Academy of Neurology.
Paula Barreras, MD	Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from American Academy of Neurology.
Richa Sharma, MD	Dr. Sharma has received research support from NIH. Dr. Sharma has received intellectual property interests from a discovery or technology relating to health care.
Matthew Pase, PhD	Dr. Pase has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheimer's Disease Drug Discovery Foundation.
Hugo Javier Aparicio, MD, MPH	Dr. Aparicio has received research support from American Academy of Neurology. Dr. Aparicio has received research support from Alzheimer's Association. Dr. Aparicio has received research support from National Institutes of Health. Dr. Aparicio has received personal compensation in the range of $10,000-$49,999 for serving as a expert panelist for the Memory & Healthy Aging Program with Cedars-Sinai.
Ajay M. Tunguturi, MD	Dr. Tunguturi has nothing to disclose.
Saurav Das, MD	Dr. Das has nothing to disclose.